T. Monster
发表
L. de Jong-van den Berg,
P. D. de Jong,
W. Janssen,
2002,
British journal of clinical pharmacology.
P. D. de Jong,
W. Janssen,
T. Monster,
2003,
Pulmonary pharmacology & therapeutics.
H. Sørensen,
J. Mclaughlin,
S. Friis,
2005,
American journal of therapeutics.
H. Sørensen,
J. Mclaughlin,
S. Friis,
2005,
The American journal of medicine.
L. de Jong-van den Berg,
P. D. de Jong,
J. Atthobari,
2003,
British journal of clinical pharmacology.
L. de Jong-van den Berg,
P. D. de Jong,
W. Janssen,
2001,
Archives of Internal Medicine.
L. de Jong-van den Berg,
P. D. de Jong,
T. B. Monster,
2003,
Pharmacoepidemiology and drug safety.
L. de Jong-van den Berg,
J. Brouwers,
Lolkje T W de Jong-van den Berg,
2003,
Journal of clinical psychopharmacology.
J. Brouwers,
L. J. D. Berg,
C. Rijcken,
2003
.
H. Sørensen,
J. Mclaughlin,
J. Rungby,
2006,
American journal of therapeutics.
H. Sørensen,
J. Mclaughlin,
M. L. Olsen,
2004,
The American journal of medicine.
L. de Jong-van den Berg,
P. D. de Jong,
W. Janssen,
2002,
Pharmacoepidemiology and drug safety.
P. Mol,
J. Hugtenburg,
P. Denig,
2020,
Drug Safety.
B. M. Rasmussen,
A. M. Foster,
S. Bandinelli,
2004,
Diabetologia.
P. Mol,
P. Denig,
Esther de Vries,
2022,
Drug Safety.
H. Tobi,
L. de Jong-van den Berg,
E. Schirm,
2004,
Pharmacoepidemiology and drug safety.